Denali Therapeutics (D2NL34.SA) Q2 2025 Earnings

6MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-4.66
-4.24
-3.81
-3.38

Details

Expected EPS
-3.9795520541000005
Actual EPS
-4.456686
Surprise EPS
-0.48
Surprise Percent
+11.99%

Description

Denali Therapeutics (D2NL34.SA) has reported earnings of -4.456686 per share for Q2 2025.

0 Comments

Share your thoughts